Andrew James King - Net Worth and Insider Trading
Andrew James King Net Worth
The estimated net worth of Andrew James King is at least $773,751 dollars as of 2024-12-27. Andrew James King is the Chief Scientific Officer of Chinook Therapeutics Inc and owns about 19,157 shares of Chinook Therapeutics Inc (KDNY) stock worth over $773,751. Details can be seen in Andrew James King's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew James King has not made any transactions after 2023-08-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew James King
Andrew James King Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew James King owns 2 companies in total, including Aduro Biotech Inc (ADRO) , and Chinook Therapeutics Inc (KDNY) .
Click here to see the complete history of Andrew James King’s form 4 insider trades.
Insider Ownership Summary of Andrew James King
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADRO | Aduro Biotech Inc | 2020-10-05 | Head of Renal Discovery |
| KDNY | Chinook Therapeutics Inc | 2023-08-01 | Head of Renal Discovery |
Andrew James King Latest Holdings Summary
Andrew James King currently owns a total of 1 stock. Andrew James King owns 19,157 shares of Chinook Therapeutics Inc (KDNY) as of August 1, 2023, with a value of $773,751.
Latest Holdings of Andrew James King
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KDNY | Chinook Therapeutics Inc | 2023-08-01 | 19,157 | 40.39 | 773,751 |
Holding Weightings of Andrew James King
Andrew James King Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew James King has made a total of 13 transactions in Chinook Therapeutics Inc (KDNY) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Chinook Therapeutics Inc is the sale of 1,168 shares on August 1, 2023, which brought Andrew James King around $45,587.
Insider Trading History of Andrew James King
- 1
Andrew James King Trading Performance
Andrew James King Ownership Network
Andrew James King Owned Company Details
What does Aduro Biotech Inc do?
Who are the key executives at Aduro Biotech Inc?
Andrew James King is the Head of Renal Discovery of Aduro Biotech Inc. Other key executives at Aduro Biotech Inc include director & President & CEO Eric Dobmeier , 10 percent owner Versant Voyageurs I, L.p. , and 10 percent owner Versant Voyageurs I Parallel, L.p. .
Aduro Biotech Inc (ADRO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aduro Biotech Inc Insider Transactions
Andrew James King Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew James King. You might contact Andrew James King via mailing address: C/o Chinook Therapeutics U.s., Inc., 1600 Fairview Ave. E., Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
